PDCD1 and neoplasm: Finally, another study had shown that anti-PD-1 treatment in association with inhibition of the methyltransferase EZH2 induced an increase of intratumoral activated CD8+ T cells and M1 tumor-associated macrophages (TAMs), reducing tumor growth [154].